Puissance Cross-Border Opportunities III LLC 4
4 · Bellerophon Therapeutics, Inc. · Filed Apr 20, 2020
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2020-04-17−553,250→ 0 total(indirect: By LLC)
Footnotes (2)
- [F1]Puissance Cross-Border Opportunities III LLC made an in-kind distribution of an aggregate 553,250 shares of the Issuer's common stock to its limited partners in connection with the redemption of partnership interests.
- [F2]These securities are held directly by Puissance Cross-Border Opportunities III LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities III LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities III LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.